Logo image of BTN

BALLANTYNE STRONG INC (BTN) Stock Fundamental Analysis

NYSEARCA:BTN - NYSE Arca - US0585161054 - Common Stock - Currency: USD

2.58  -0.02 (-0.96%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to BTN. BTN was compared to 71 industry peers in the Entertainment industry. BTN has a bad profitability rating. Also its financial health evaluation is rather negative. BTN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BTN had negative earnings in the past year.
In the past year BTN has reported a negative cash flow from operations.
BTN Yearly Net Income VS EBIT VS OCF VS FCFBTN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 10M -10M

1.2 Ratios

The profitability ratios for BTN are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BTN Yearly ROA, ROE, ROICBTN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 20 -20

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BTN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BTN Yearly Profit, Operating, Gross MarginsBTN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 -20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

BTN does not have a ROIC to compare to the WACC, probably because it is not profitable.
BTN has more shares outstanding than it did 1 year ago.
The debt/assets ratio for BTN has been reduced compared to a year ago.
BTN Yearly Shares OutstandingBTN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 5M 10M 15M
BTN Yearly Total Debt VS Total AssetsBTN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M

2.2 Solvency

BTN has an Altman-Z score of 2.00. This is not the best score and indicates that BTN is in the grey zone with still only limited risk for bankruptcy at the moment.
BTN has a Altman-Z score of 2.00. This is in the better half of the industry: BTN outperforms 65.22% of its industry peers.
A Debt/Equity ratio of 0.11 indicates that BTN is not too dependend on debt financing.
BTN has a Debt to Equity ratio (0.11) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 2
ROIC/WACCN/A
WACC9.79%
BTN Yearly LT Debt VS Equity VS FCFBTN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M 40M

2.3 Liquidity

A Current Ratio of 1.28 indicates that BTN should not have too much problems paying its short term obligations.
BTN has a Current ratio (1.28) which is in line with its industry peers.
A Quick Ratio of 1.02 indicates that BTN should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.02, BTN perfoms like the industry average, outperforming 42.03% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 1.02
BTN Yearly Current Assets VS Current LiabilitesBTN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for BTN have decreased strongly by -1075.00% in the last year.
The Revenue has been growing slightly by 2.62% in the past year.
BTN shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -18.73% yearly.
EPS 1Y (TTM)-1075%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-128.95%
Revenue 1Y (TTM)2.62%
Revenue growth 3Y-25.24%
Revenue growth 5Y-18.73%
Sales Q2Q%67.99%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BTN Yearly Revenue VS EstimatesBTN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M
BTN Yearly EPS VS EstimatesBTN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 0.02 0.04 0.06 0.08 0.1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BTN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BTN Price Earnings VS Forward Price EarningsBTN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BTN Per share dataBTN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BTN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BALLANTYNE STRONG INC

NYSEARCA:BTN (12/23/2022, 8:27:18 PM)

2.58

-0.02 (-0.96%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)N/A N/A
Earnings (Next)03-22 2023-03-22
Inst Owners4.94%
Inst Owner Change-60.74%
Ins Owners5.67%
Ins Owner Change0%
Market Cap50.23M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.27
P/FCF N/A
P/OCF N/A
P/B 1.13
P/tB 1.19
EV/EBITDA N/A
EPS(TTM)-0.47
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS2.03
BVpS2.29
TBVpS2.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 127.67%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.28
Quick Ratio 1.02
Altman-Z 2
F-Score2
WACC9.79%
ROIC/WACCN/A
Cap/Depr(3y)79.53%
Cap/Depr(5y)92.96%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1075%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-128.95%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.62%
Revenue growth 3Y-25.24%
Revenue growth 5Y-18.73%
Sales Q2Q%67.99%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y62.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-129.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-108.6%
OCF growth 3YN/A
OCF growth 5Y28.99%